Pentosan reduces osteonecrosis of femoral head in SHRSP

Clinical and Experimental Hypertension

Volumn 32, Issue 8, 2010, Pages 511-516

  Miyata, Noriaki ^a   Kumagai, Kenji ^a   Osaki, Makoto ^a   Murata, Masakazu ^a   Tomita, Masato ^a   Hozumi, Akira ^a   Nozaki, Yoshihiro ^a   Niwa, Masami ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

femoral head; hypertension; osteonecrosis; pentosan; rat; SHRSP; steroid

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METHYLPREDNISOLONE ACETATE; PENTOSAN POLYSULFATE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; FEMUR HEAD NECROSIS; HISTOPATHOLOGY; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; MALE; NONHUMAN; OXIDATIVE STRESS; PARTIAL THROMBOPLASTIN TIME; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOOD COAGULATION; DISEASE MODELS, ANIMAL; FEMUR HEAD NECROSIS; LIPID METABOLISM; MALE; METHYLPREDNISOLONE; OXIDATIVE STRESS; PENTOSAN SULFURIC POLYESTER; RATS; RATS, INBRED SHR;

EID: 79251503015     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2010.496511     Document Type: Article

References (23)

1. Hirota Y. Etiology of idiopathic osteonecrosis of the femoral head: nationwide epidemiologic studies in Japan. In: Osteonecrosis: Etiology, Diagnosis, and Treatmen, 1997, 51-58.
2. Ichiseki T, Kaneuji A, Katsuda S, Ueda Y, Sugimori T, Matsumoto T. DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology (Oxford) 2005, 44:456-460.
3. Fisher DE.. The role of fat embolism in the etiology of corticosteriud-induced avascular necrosis: clinical and experimental results. Clin Orthop 1978;130:68-80.
4. Zhang G, Qin L, Sheng H, et al. A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner. Bone 2009;44:345-356.
5. Murata M, Kumagai K, Miyata N, Osaki M, Shindo H. Osteonecrosis in stroke-prone spontaneously hypertensive rats: Effect of glucocorticoid. J Orthop Sci 2007:12:289-295.
6. Arlet J. A traumatic necrosis of the femoral head: General report. In: Schoutens A, Arlet J, Gardeniers JWM, Hughes SPF, eds., Bone Circulation and Vascularization in Normal and Pathological Conditions. New York: Plenum, 1993, 235-240.
7. Atsumi T, Muraki M, Yoshihara S, Kajihara T. Posterior rotational osteotomy for the treatment of femoral head osteonecrosis. Arch Orthop Trauma Surg 1999;119:388-393.
8. Sugioka Y. Transtrochanteric anterior rotational osteotomy of the femoral head in the treatment of osteonecrosis affecting the hip: a new osteotomy operation. Clin Orthop Relat Res 1978;130:191-201.
9. Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: Ten years later. J Bone Joint Surg Am 2006;88:1117-1132.
10. Yamori Y. Development of the spontaneously hypertensive rat (SHR) and of various spontaneous rat models, and their implications. In: de Jong W, ed., Handbook of Hypertension, Experimental and Genetic Models of Hypertension, Volume 4. Amsterdam: Elsevier Science Publishers BV; 1984, 224-239.
11. Wada M, Kumagai K, Murata M, Yamashita S-Y, Shindo H. Warfarin reduces the incidence of osteonecrosis of the femoral head in spontaneously hypertensive rats. J Orthop Sci 2004;9:585-590.
12. Iwasaki K, Hirano T, Sagara K, Nishimura Y. Idiopathic necrosis of the femoral epiphyseal nucleus in rats. Clin Orthop 1992;277:31-40.
13. Hirano T, Iwasaki K, Sagara K, Nishimura Y, Kumashiro T. Necrosis of the femoral head in growing rats. Occlusion of lateral epiphyseal vessels. Acta Orthop Scand 1989;60:407-410.
14. Suzuki M, Kumagai K, Osaki M, Murata M, Tomita M, Miyata N, Hozumi A, Niwa M. Osteonecrosis of femoral head in the stroke-prone spontaneously hypertensive rats, especially old rats. Clin Exp Hypertens 2008;30:689-697.
15. Boss JH, Misselevich I, Peskin B, Zinman C, Levin D, Norman D, Reis DN. Postosteonecrotic osteoarthritis-like disorder of the femoral head of rats. J Comp Pathol 2003;129:235-239.
16. Yagi S, Aihara K, Ikeda Y, Sumitomo Y, Yoshida S, Ise T, Iwase T, Ishikawa K, Azuma H, Akaike M, Matsumoto T. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency. Circ Res 2008;102:68-76.
17. Ichiseki T, Ueda Y, Katsuda S, Kitamura K, Kaneuji A, Matsumoto T. Oxidative stress by glutathione depletion induces osteonecrosis in rats. Rheumatology (Oxford) 2006;45:287-290.
18. Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y. Combined effects of an anticoagulant and a lipidlowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum 2004;50:3387-3391.
19. Iwakiri K, Oda Y, Kaneshiro Y, Iwaki H, Masada T, Kobayashi A, Asada A, Takaoka K. Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model. J Orthop Sci 2008;13:463-468.
20. Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Matsumoto T. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 2003;92:81-87.
21. Nagasawa K, Tada Y, Koarada S, Tsukamoto H, Horiuchi T, Yoshizawa S, Murai K, Ueda A, Haruta Y, Ohta A. Prevention of steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant. Lupus 2006;15:354-357.
22. Cheras PA. Role of hyperlipidemia, hypercoagulability, and hypofibrinolysis in osteonecrosis and osteoarthritis. In: Urbaniak JR, Jones JP Jr, eds., Osteonecrosis: Etiology, Diagnosis, and Treatment. Rosemont, IL: American Academy of Orthopedic Surgeons, 1997, 97-104.
23. Ghosh P. The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment. Semin Arthritis Rheum 1999;28:211-267.